RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $292,692 (100.0% shares, 0.0% debt)

Holdings (35)

ALNY Alnylam Pharmaceuticals Inc 15.8%

Value ($000) $46,198 Shares 832,549 Est. Cost $88.29 Unrealized -28.6%

INCY Incyte Corp 10.7%

Value ($000) $31,371 Shares 392,236 Est. Cost $74.63 Unrealized +4.0%

— bluebird bio Inc 9.1%

Value ($000) $26,495 Shares 612,025 Est. Cost $43.60 Unrealized —

— Achillion Pharmaceuticals Inc 6.5%

Value ($000) $18,908 Shares 2,424,136 Est. Cost $10.21 Unrealized —

— La Jolla Pharmaceutical Co 6.4%

Value ($000) $18,818 Shares 1,176,146 Est. Cost $25.02 Unrealized —

— Avexis Inc 6.2%

Value ($000) $18,111 Shares 476,367 Est. Cost $27.24 Unrealized —

BMY Bristol-Myers Squibb Co 5.3%

Value ($000) $15,424 Shares 209,701 Est. Cost $48.14 Unrealized +4.9%

— Kite Pharma Inc 4.9%

Value ($000) $14,276 Shares 285,518 Est. Cost $58.27 Unrealized —

— Symmetry Surgical Inc 4.1%

Value ($000) $12,109 Shares 922,215 Est. Cost $8.83 Unrealized —

GLD SPDR Gold Shares ETF 3.6%

Value ($000) $10,497 Shares 83,000 Est. Cost $126.47 Unrealized —

— Atara Biotherapeutics Inc. 3.6%

Value ($000) $10,487 Shares 465,874 Est. Cost $25.80 Unrealized —

— Agenus Inc 3.4%

Value ($000) $9,838 Shares 2,429,149 Est. Cost $7.99 Unrealized —

BCRX BioCryst Pharmaceuticals Inc 2.2%

Value ($000) $6,353 Shares 2,237,066 Est. Cost $10.11 Unrealized -69.3%

TLT iShares 20+ Year Treasury Bond ETF 2.1%

Value ($000) $6,251 Shares 45,000 Est. Cost $133.37 Unrealized —

— Dicerna Pharmaceuticals Inc 2.1%

Value ($000) $6,081 Shares 2,026,894 Est. Cost $13.12 Unrealized —

— Intercept Pharmaceuticals Inc 1.9%

Value ($000) $5,636 Shares 39,500 Est. Cost $142.68 Unrealized —

— Celldex Therapeutics Inc 1.9%

Value ($000) $5,550 Shares 1,264,227 Est. Cost $12.18 Unrealized —

OMER Omeros Corp 1.9%

Value ($000) $5,542 Shares 526,788 Est. Cost $14.29 Unrealized -13.9%

— Viveve Medical Inc 1.1%

Value ($000) $3,341 Shares 814,946 Est. Cost $4.10 Unrealized —

— Barclays Bank iPath Dow Jones-UBS Coffee Subindex TR ETN 1.1%

Value ($000) $3,194 Shares 144,200 Est. Cost $22.15 Unrealized —

— Corium International Inc 1.0%

Value ($000) $2,960 Shares 852,961 Est. Cost $10.20 Unrealized —

— Invuity Inc 0.7%

Value ($000) $2,154 Shares 226,042 Est. Cost $12.89 Unrealized —

RGNX Regenxbio Inc 0.7%

Value ($000) $1,942 Shares 242,784 Est. Cost $24.07 Unrealized -53.9%

— Five Prime Therapeutics Inc 0.6%

Value ($000) $1,848 Shares 44,701 Est. Cost $22.81 Unrealized —

— Global Blood Therapeutics Inc 0.6%

Value ($000) $1,612 Shares 97,138 Est. Cost $35.72 Unrealized —

MASI Masimo Corp 0.5%

Value ($000) $1,360 Shares 25,900 Est. Cost $40.86 Unrealized +15.3%

— Accelerate Diagnostics Inc 0.4%

Value ($000) $1,077 Shares 74,843 Est. Cost $20.90 Unrealized —

— CytRx Corp 0.4%

Value ($000) $1,040 Shares 466,200 Est. Cost $2.73 Unrealized —

— Sensus Healthcare Inc 0.3%

Value ($000) $1,006 Shares 155,000 Est. Cost $6.49 Unrealized —

— MNKD 01/20/2017 PUT 3 0.3%

Value ($000) $912 Shares 4,385 Est. Cost — Unrealized —

— Mirati Therapeutics Inc 0.2%

Value ($000) $716 Shares 131,052 Est. Cost $33.11 Unrealized —

MDRX Allscripts Healthcare Solutions Inc 0.2%

Value ($000) $610 Shares 48,000 Est. Cost $13.76 Unrealized -3.7%

— Biopharmx Corp 0.2%

Value ($000) $455 Shares 700,636 Est. Cost $1.87 Unrealized —

NTRA Natera Inc 0.1%

Value ($000) $382 Shares 31,693 Est. Cost $16.90 Unrealized -34.2%

— Nivalis Therapeutics Inc 0.0%

Value ($000) $138 Shares 30,000 Est. Cost $15.17 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals Inc	832,549	$46,198	15.8%	$88.29	-28.6%	COM	02043Q107
INCY	Incyte Corp	392,236	$31,371	10.7%	$74.63	+4.0%	COM	45337C102
—	bluebird bio Inc	612,025	$26,495	9.1%	$43.60	—	COM	09609G100
—	Achillion Pharmaceuticals Inc	2,424,136	$18,908	6.5%	$10.21	—	COM	00448Q201
—	La Jolla Pharmaceutical Co	1,176,146	$18,818	6.4%	$25.02	—	COM PAR $.0001 2	503459604
—	Avexis Inc	476,367	$18,111	6.2%	$27.24	—	COM	05366U100
BMY	Bristol-Myers Squibb Co	209,701	$15,424	5.3%	$48.14	+4.9%	COM	110122108
—	Kite Pharma Inc	285,518	$14,276	4.9%	$58.27	—	COM	49803L109
—	Symmetry Surgical Inc	922,215	$12,109	4.1%	$8.83	—	COM	87159G100
GLD	SPDR Gold Shares ETF	83,000	$10,497	3.6%	$126.47	—	GOLD SHS	78463V107
—	Atara Biotherapeutics Inc.	465,874	$10,487	3.6%	$25.80	—	COM	046513107
—	Agenus Inc	2,429,149	$9,838	3.4%	$7.99	—	COM NEW	00847G705
BCRX	BioCryst Pharmaceuticals Inc	2,237,066	$6,353	2.2%	$10.11	-69.3%	COM	09058V103
TLT	iShares 20+ Year Treasury Bond ETF	45,000	$6,251	2.1%	$133.37	—	20 YR TR BD ETF	464287432
—	Dicerna Pharmaceuticals Inc	2,026,894	$6,081	2.1%	$13.12	—	COM	253031108
—	Intercept Pharmaceuticals Inc	39,500	$5,636	1.9%	$142.68	—	COM	45845P108
—	Celldex Therapeutics Inc	1,264,227	$5,550	1.9%	$12.18	—	COM	15117B103
OMER	Omeros Corp	526,788	$5,542	1.9%	$14.29	-13.9%	COM	682143102
—	Viveve Medical Inc	814,946	$3,341	1.1%	$4.10	—	COM	92852W204
—	Barclays Bank iPath Dow Jones-UBS Coffee Subindex TR ETN	144,200	$3,194	1.1%	$22.15	—	ETN DJUBSCOFFE38	06739H297
—	Corium International Inc	852,961	$2,960	1.0%	$10.20	—	COM	21887L107
—	Invuity Inc	226,042	$2,154	0.7%	$12.89	—	COM NEW	46187J205
RGNX	Regenxbio Inc	242,784	$1,942	0.7%	$24.07	-53.9%	COM	75901B107
—	Five Prime Therapeutics Inc	44,701	$1,848	0.6%	$22.81	—	COM	33830X104
—	Global Blood Therapeutics Inc	97,138	$1,612	0.6%	$35.72	—	COM	37890U108
MASI	Masimo Corp	25,900	$1,360	0.5%	$40.86	+15.3%	COM	574795100
—	Accelerate Diagnostics Inc	74,843	$1,077	0.4%	$20.90	—	COM	00430H102
—	CytRx Corp	466,200	$1,040	0.4%	$2.73	—	COM PAR $.001	232828509
—	Sensus Healthcare Inc	155,000	$1,006	0.3%	$6.49	—	UNIT 99/99/9999	81728J208
—	MNKD 01/20/2017 PUT 3	4,385	$912	0.3%	—	—	Put	56400P201
—	Mirati Therapeutics Inc	131,052	$716	0.2%	$33.11	—	COM	60468T105
MDRX	Allscripts Healthcare Solutions Inc	48,000	$610	0.2%	$13.76	-3.7%	COM	01988P108
—	Biopharmx Corp	700,636	$455	0.2%	$1.87	—	COM	09072X101
NTRA	Natera Inc	31,693	$382	0.1%	$16.90	-34.2%	COM	632307104
—	Nivalis Therapeutics Inc	30,000	$138	0.0%	$15.17	—	COM	65481J109